Whole lotus rhizome or defined lotus-root juice,
does it really help with Reduction of menstrual blood loss in heavy menstrual bleeding?
research showsJudgment is deferred. No eligible human trial was identified that assigned whole lotus rhizome or a defined lotus-root juice to adults with heavy menstrual bleeding and compared PBAC or objective blood loss. Classical hemostatic records, traditional use of lotus leaf for uterine bleeding, rhizome nodes, carbonized products, and combination formulas are different interventions.
ads claimDo not advertise it as a hemostatic food, a menstrual-loss or anemia treatment, or a replacement for hormonal or other standard gynecologic care.
Useful facts when choosing a product
- This verdict applies only to the displayed lotus part, formulation, route, population, claim, endpoint, and comparator.
- Leaf, plumule, whole seed, rhizome, node, tea, extract, food, juice, and combination products are not interchangeable.
- Caution. Food-use experience does not establish the safety of therapeutic-dose lotus-root juice. A human anaphylaxis case involving lotus root has been reported (PMID 32232879), while incidence, dose, cooking form, pregnancy, lactation, kidney or liver disease, and interactions with anticoagulants or antiplatelets remain unverified.
Chamgap Semantic Classification Code
Candidate index · review held
F.lotus-rhizome.oral-food-or-juice.heavy-menstrual-bleeding-pbac.reduce.UNKFoods and beverages > Whole lotus rhizome > Food or juice > Heavy-menstrual-bleeding PBAC or blood loss > Reduction claim > Comparator unknown
This is separated from the cough and sputum claim in verdict 1965. Permanent issuance is held because no eligible human study directly tested whole lotus root or juice for menstrual blood loss. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.
Exact Claim Classification
These independent facets prevent evidence from different forms, routes, populations, effects, and comparators from being mixed.
| Intervention class | F · Food, ingredient, or beverage |
|---|---|
| Canonical ingredient or intervention | Whole lotus rhizome or lotus-root juice |
| Source or part used | Whole edible underground rhizome of Nelumbo nucifera; nodes and carbonized products excluded |
| Formulation or processing | Whole food or defined lotus-root juice; no eligible trial formulation verified |
| Route | Oral food intake |
| Dose | Unverified (no eligible human trial) |
| Duration | Unverified (no eligible human trial) |
| Population | Adults with heavy menstrual bleeding |
| Effect or condition | Reduced menstrual blood loss |
| Primary endpoint | Unverified; intended endpoint is PBAC or objective menstrual blood loss |
| Comparator | Unverified (no eligible human trial) |
| Duplicate-detection key | Whole lotus rhizome or lotus-root juice|Whole food or defined lotus-root juice; no eligible trial formulation verified|Oral food intake|Adults with heavy menstrual bleeding|Reduced menstrual blood loss|Unverified (no eligible human trial) |
What the research actually shows
PubMed and ClinicalTrials.gov were searched using combinations of Nelumbo, lotus root, rhizome, juice, menorrhagia, heavy menstrual bleeding, and PBAC; a human antioxidant root trial, traditional-use reviews, and a human allergy case were separated by endpoint and safety role.
Why this is classified as ?
No evidence axes are scored because no eligible human trial directly linked whole lotus root or juice to menstrual blood loss in heavy menstrual bleeding; the grade remains ?.
Counterpoint. Eating lotus root as food and repeatedly taking a therapeutic quantity of juice are different safety contracts. An evidence gap is not converted into efficacy or harmlessness.
Rejudgment record. Independent Codex cross-check — One exact plant part, formulation, population, claim, endpoint, and comparator
Cross-check — AI research and Codex final gate
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| In Vivo Antioxidant Properties of Lotus Root and Cucumber: A Pilot Comparative Study in Aged Subjects | Design and eligibility were independently checked. | Funding, product supply, employee authorship, and conflicts were assessed separately. | The endpoint was checked against the page claim. | No missing effect estimate or confidence interval was invented. | Eligibility reflects the exact plant part, formulation, population, endpoint, and comparator. | |
| Phytochemical Profile and Biological Activity of Nelumbo nucifera | Design and eligibility were independently checked. | Funding, product supply, employee authorship, and conflicts were assessed separately. | The endpoint was checked against the page claim. | No missing effect estimate or confidence interval was invented. | Eligibility reflects the exact plant part, formulation, population, endpoint, and comparator. | |
| Case of anaphylaxis due to lotus root | Design and eligibility were independently checked. | 1 | Funding, product supply, employee authorship, and conflicts were assessed separately. | The endpoint was checked against the page claim. | No missing effect estimate or confidence interval was invented. | Eligibility reflects the exact plant part, formulation, population, endpoint, and comparator. |
Receipt — 3 References
All 3 cited sources were verified for existence at the original page (as of 2026-09-08).
Final verification and publication gate: Codex · Verification cutoff: 2026-09-08 · Corrections: none
Cite this verdict
[Chamgap] Whole Lotus Root or Juice for Heavy Menstrual Bleeding—No Direct Eligible Human Trial Was Identified — Evidence Grade ?. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/womens/whole-lotus-rhizome-juice-heavy-menstrual-bleeding/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.